- Home
- XTLB vs SRFM Comparison
XTLB vs SRFM Comparison
Compare XTLB & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- SRFM
- Stock Information
- Founded
- XTLB 1993
- SRFM 2011
- Country
- XTLB Israel
- SRFM United States
- Employees
- XTLB 4
- SRFM N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- SRFM Transportation Services
- Sector
- XTLB Health Care
- SRFM Consumer Discretionary
- Exchange
- XTLB Nasdaq
- SRFM Nasdaq
- Market Cap
- XTLB 7.8M
- SRFM 62.8M
- IPO Year
- XTLB 2005
- SRFM 2023
- Fundamental
- Price
- XTLB $1.44
- SRFM $3.33
- Analyst Decision
- XTLB
- SRFM Hold
- Analyst Count
- XTLB 0
- SRFM 2
- Target Price
- XTLB N/A
- SRFM $3.40
- AVG Volume (30 Days)
- XTLB 12.9K
- SRFM 604.8K
- Earning Date
- XTLB 02-20-2025
- SRFM 11-14-2024
- Dividend Yield
- XTLB N/A
- SRFM N/A
- EPS Growth
- XTLB N/A
- SRFM N/A
- EPS
- XTLB N/A
- SRFM N/A
- Revenue
- XTLB N/A
- SRFM $118,212,000.00
- Revenue This Year
- XTLB N/A
- SRFM $102.41
- Revenue Next Year
- XTLB N/A
- SRFM $47.46
- P/E Ratio
- XTLB N/A
- SRFM N/A
- Revenue Growth
- XTLB N/A
- SRFM 198.78
- 52 Week Low
- XTLB $0.76
- SRFM $0.90
- 52 Week High
- XTLB $4.99
- SRFM $11.83
- Technical
- Relative Strength Index (RSI)
- XTLB 30.57
- SRFM 50.96
- Support Level
- XTLB $1.42
- SRFM $2.76
- Resistance Level
- XTLB $1.83
- SRFM $4.50
- Average True Range (ATR)
- XTLB 0.12
- SRFM 0.81
- MACD
- XTLB -0.04
- SRFM -0.18
- Stochastic Oscillator
- XTLB 3.13
- SRFM 20.92
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.